Genetic Testing: Hypercoagulability/Thrombophilia
Customize your policy alerts
Sign up for Presbyterian Health Plan Policy 7.11 alerts
Get alerted when Policy 7.11 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage and prior authorization for germline Factor II (F2) and Factor V (F5) genetic testing, as well as non-coverage of MTHFR testing, repeat germline testing, and certain VTE risk-score testing for Commercial, Medicaid, and Medicare members, subject to the member-specific benefit plan and Schedule of Benefits.
Added non-coverage language for CPT 0529U, a genome-wide SNP VTE risk score including F2 and F5 analysis.
Clarified that repeat germline testing billed with CPT 81240 or 81241 more than once in a lifetime is non-covered for Commercial, Medicare, and Medicaid members.
Moved the annual review of MTHFR non-coverage from MPM 36.0 into this policy.
Clarified that Medicaid coverage for Factor II and Factor V testing follows CMS/Novitas LCD guidance.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.